Roseola future or investigational therapies: Difference between revisions
Jump to navigation
Jump to search
Category |
m Bot: Removing from Primary care |
||
Line 9: | Line 9: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Emergency mdicine]] | |||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Up-To-Date]] | [[Category:Up-To-Date]] | ||
[[Category:Infectious disease]] | [[Category:Infectious disease]] |
Latest revision as of 00:03, 30 July 2020
Roseola Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Roseola future or investigational therapies On the Web |
American Roentgen Ray Society Images of Roseola future or investigational therapies |
Risk calculators and risk factors for Roseola future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omodamola Aje B.Sc, M.D. [2]